Stanley Center for Psychiatric Research

An ever-increasing number of genetic variants, both rare and common, are being associated with psychiatric disease. The Stanley Center for Psychiatric Research has initiated the Target Practice program to fund innovative projects ($250,000 total costs for one year) to focus on translating these emerging genetic findings into novel mechanism-based therapeutic approaches for severe mental illnesses. Applications are invited from the scientific community to address this challenge on a rolling basis.